Dentalcorp Obtains Final Court Approval for Acquisition by Investment Funds Affiliated With GTCR

Executive Summary

• Dentalcorp Holdings Ltd. received final approval from the Supreme Court of British Columbia for its previously announced plan of arrangement to be acquired by a GTCR‑controlled vehicle.
• The acquisition will purchase all outstanding subordinate voting and multiple voting shares (excluding certain insider holdings) at C$11.00 per share in cash.
• Subject to customary closing conditions, including Investment Canada Act approval, the transaction is expected to close in Q1 2026.

Key Details

• Transaction Structure: GTCR‑controlled acquisition vehicle will acquire Dentalcorp’s issued and outstanding subordinate voting shares and multiple voting shares (the “Shares”).
• Exclusions: Shares owned by Founder/Chairman & CEO Graham Rosenberg, President & CFO Nate Tchaplia, and partner dentists electing to roll their shares are excluded.
• Purchase Price: C$11.00 per Share in cash.
• Court Approval: Final order from the Supreme Court of British Columbia confirming the plan of arrangement.
• Securityholder Approval: Obtained at a special meeting on 4 December 2025.
• Closing Conditions: Subject to customary conditions, including approval under the Investment Canada Act.
• Expected Closing: Anticipated during the first quarter of 2026, assuming timely receipt of all required approvals.
• Reference Documents: Management Information Circular dated 4 November 2025 filed on SEDAR+.

Notable Quotes

(No direct quotes were included in the release.)